Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 2011. 25: 2269-2278. PMID: 21941167

Year

2011

Journal

AIDS

Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase

Jessica H. Brehm, Christina M. Lalama, Michael Hughes, Richard H. Haubrich, Sharon A. Riddler, Nicolas Sluis-Cremer, John W. Mellors. Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2011. 56: 344-8. PMID: 21350368

Year

2011

Journal

Journal of Acquired Immune Deficiency Syndromes

No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT

Heather Ribaudo, Constance A. Benson, Yu (Evelyn) Zheng, Susan L. Koletar, Ann C. Collier, Judith J. Lok, Marlene Smurzynski, Ronald J. Bosch, Barbara Bastow, Jeffrey T. Schouten. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clinical Infectious Diseases. 2011. 52: 929-40. PMID: 21427402

Year

2011

Journal

Clinical Infectious Diseases